Sangamo Therapeutics Inc (SGMO)
0.4895
-0.03
(-5.56%)
USD |
NASDAQ |
Apr 18, 16:00
0.4895
0.00 (0.00%)
After-Hours: 16:24
Sangamo Therapeutics Total Liabilities (Quarterly): 82.43M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.43M |
| September 30, 2023 | 84.78M |
| June 30, 2023 | 91.43M |
| March 31, 2023 | 104.96M |
| December 31, 2022 | 267.55M |
| September 30, 2022 | 284.76M |
| June 30, 2022 | 298.84M |
| March 31, 2022 | 319.79M |
| December 31, 2021 | 346.58M |
| September 30, 2021 | 366.38M |
| June 30, 2021 | 389.91M |
| March 31, 2021 | 407.68M |
| December 31, 2020 | 441.18M |
| September 30, 2020 | 442.83M |
| June 30, 2020 | 383.45M |
| March 31, 2020 | 189.86M |
| December 31, 2019 | 204.78M |
| September 30, 2019 | 220.89M |
| June 30, 2019 | 227.73M |
| March 31, 2019 | 213.55M |
| December 31, 2018 | 223.14M |
| September 30, 2018 | 226.70M |
| June 30, 2018 | 239.86M |
| March 31, 2018 | 98.80M |
| December 31, 2017 | 98.84M |
| Date | Value |
|---|---|
| September 30, 2017 | 83.14M |
| June 30, 2017 | 88.95M |
| March 31, 2017 | 21.13M |
| December 31, 2016 | 21.70M |
| September 30, 2016 | 21.14M |
| June 30, 2016 | 20.88M |
| March 31, 2016 | 17.64M |
| December 31, 2015 | 24.80M |
| September 30, 2015 | 28.96M |
| June 30, 2015 | 30.00M |
| March 31, 2015 | 31.02M |
| December 31, 2014 | 36.58M |
| September 30, 2014 | 37.21M |
| June 30, 2014 | 36.48M |
| March 31, 2014 | 38.08M |
| December 31, 2013 | 19.13M |
| September 30, 2013 | 14.22M |
| June 30, 2013 | 14.82M |
| March 31, 2013 | 14.26M |
| December 31, 2012 | 17.64M |
| September 30, 2012 | 15.41M |
| June 30, 2012 | 16.08M |
| March 31, 2012 | 16.08M |
| December 31, 2011 | 7.204M |
| September 30, 2011 | 4.144M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
82.43M
Minimum
Dec 2023
442.83M
Maximum
Sep 2020
271.36M
Average
284.76M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Electromed Inc | 6.622M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.32M |
| Shareholders Equity (Quarterly) | 82.89M |
| Current Ratio | 1.976 |